| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
? － ? |
Cefoperazone (Cefobid)  |
1389 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
? － ? |
Cefoxitin (Mefoxin) |
1389 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
4 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
36 |
| Staphylococcus aureus (methicillin-susceptible) |
>2 |
>8 |
0.25 － 64 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
948 |
| Staphylococcus aureus (methicillin-susceptible) |
3 |
4 |
0.06 － 32 |
Gentamicin (Gentamycin, Garamycin) |
1056 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.12 － 32 |
Ceftriaxone (Rocephin) |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.125 － 32 |
Ceftriaxone (Rocephin) |
113 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.5 － 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
7 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.5 － >64 |
Ceftriaxone (Rocephin) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
2 － 8 |
Cefteram |
317 |
| Staphylococcus aureus (methicillin-susceptible) |
≤4 |
≤4 |
≤4 － ? |
Mupirocin (Bactroban) |
604 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
0.5 － 16 |
Cefaclor (Ceclor, Ceclor CD) |
120 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
0.5 － 32 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
1464 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
2 － 16 |
Ceftriaxone (Rocephin) |
371 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
? － ? |
Moxalactam (Latamoxef) |
1389 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
16 |
≤0.125 － ? |
MSI-78 (Peptide) |
65 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
16 |
? － ? |
Ceftriaxone (Rocephin) |
36 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
32 |
≤0.015 － >32 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
371 |
| Staphylococcus aureus (methicillin-susceptible) |
>=4 |
≥32 |
≤0.06 － >=32 |
Ampicillin (Omnipen) |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
4 |
64 |
0.125 － 64 |
Gentamicin (Gentamycin, Garamycin) |
1464 |
| Staphylococcus aureus (methicillin-susceptible) |
8 |
8 |
2 － >64 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
8 |
8 |
2 － >64 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
8 |
8 |
4 － 8 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1491 |
| Staphylococcus aureus (methicillin-susceptible) |
>=8 |
≥16 |
≤0.06 － >=16 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
>8 |
>16 |
? － ? |
Ampicillin (Omnipen) |
36 |
| Staphylococcus aureus (methicillin-susceptible) |
8 |
64 |
0.06 － 128 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
178 |
| Staphylococcus aureus (methicillin-susceptible) |
16 |
16 |
2 － 32 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
113 |
| Staphylococcus aureus (methicillin-susceptible) |
16 |
16 |
2 － 32 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
113 |